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Within hosts, Human T-Lymphotropic Virus Type-1
(HTLV-1) is spread through de novo infection and
infected cell proliferation, producing multiple T cell
clones (infected cells with the same genomic proviral
integration site). Between hosts, the number of clones
observed from a 10μg sample of DNA varies by up to
three orders of magnitude. The question arises: what is
the total number of clones in the host from which that
sample was drawn? Considering each clone as a “spe-
cies”, the question becomes analogous to the “unseen
species problem” in population ecology. We tested four
species richness (number of species) estimators, and a
novel approach, “DivE”, using three independent data-
sets: (i) viral populations from patients infected with
HTLV-1, (ii) T cell antigen receptor clonotype reper-
toires, and (iii) microbial data from infant faecal sam-
ples. In all datasets, DivE was substantially more
accurate than the ecological estimators, which were
strongly biased by sample size when applied to datasets
where the majority of species was not already present.
DivE can also be used to estimate with accuracy the
population clone structure from small samples. Previous
estimates of HTLV-1 clone diversity in vivo were in the
order of 102, and have increased in line with method
sensitivity. In contrast, the mean estimated number of
clones in the circulation of a single host (asymptomatic
carriers and patients with chronic inflammation) by
DivE was more than two logs higher than previously
estimated. These estimates will inform our understand-
ing of the dynamics and pathogenesis of HTLV-1
infection.
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